INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 213 filers reported holding INSMED INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $398,369 | +6.0% | 15,777 | -11.4% | 0.24% | +8.5% |
| Q2 2023 | $375,875 | +43.1% | 17,814 | +15.6% | 0.22% | +53.8% |
| Q1 2023 | $262,672 | -13.1% | 15,406 | +1.8% | 0.14% | -8.2% |
| Q4 2022 | $302,397 | +3.6% | 15,135 | +11.8% | 0.16% | +36.2% |
| Q3 2022 | $292,000 | +11.0% | 13,541 | +1.5% | 0.12% | +19.6% |
| Q2 2022 | $263,000 | -19.3% | 13,344 | -3.8% | 0.10% | -33.6% |
| Q1 2022 | $326,000 | -13.8% | 13,869 | 0.0% | 0.15% | +2.1% |
| Q4 2021 | $378,000 | -10.0% | 13,869 | -9.1% | 0.14% | -22.7% |
| Q3 2021 | $420,000 | -11.4% | 15,261 | -8.4% | 0.18% | -5.1% |
| Q2 2021 | $474,000 | -11.2% | 16,660 | +6.3% | 0.20% | -13.7% |
| Q1 2021 | $534,000 | +5.1% | 15,678 | +2.8% | 0.23% | +7.1% |
| Q4 2020 | $508,000 | -26.5% | 15,252 | -29.0% | 0.21% | -41.7% |
| Q3 2020 | $691,000 | +27.5% | 21,496 | +9.2% | 0.36% | +40.9% |
| Q2 2020 | $542,000 | +33.5% | 19,685 | -22.4% | 0.26% | +53.9% |
| Q1 2020 | $406,000 | -38.2% | 25,355 | -7.8% | 0.17% | +56.1% |
| Q4 2019 | $657,000 | +251.3% | 27,494 | +159.2% | 0.11% | +181.6% |
| Q3 2019 | $187,000 | -34.8% | 10,609 | -5.3% | 0.04% | -37.7% |
| Q2 2019 | $287,000 | +6.3% | 11,200 | -45.6% | 0.06% | +32.6% |
| Q4 2018 | $270,000 | -20.4% | 20,606 | +23.0% | 0.05% | +31.4% |
| Q3 2018 | $339,000 | -50.1% | 16,751 | -41.7% | 0.04% | -94.2% |
| Q2 2018 | $679,000 | +23.5% | 28,718 | +17.7% | 0.60% | +25.8% |
| Q1 2018 | $550,000 | +53.6% | 24,409 | +112.4% | 0.48% | +6.2% |
| Q4 2017 | $358,000 | -44.8% | 11,494 | -44.7% | 0.45% | +416.1% |
| Q3 2017 | $649,000 | +100.3% | 20,798 | +10.1% | 0.09% | +81.2% |
| Q2 2017 | $324,000 | -15.4% | 18,896 | -13.6% | 0.05% | -29.4% |
| Q1 2017 | $383,000 | +46.2% | 21,882 | +10.6% | 0.07% | -12.8% |
| Q4 2016 | $262,000 | -26.4% | 19,785 | -19.4% | 0.08% | -54.7% |
| Q3 2016 | $356,000 | +47.1% | 24,536 | 0.0% | 0.17% | -4.4% |
| Q2 2016 | $242,000 | +29.4% | 24,536 | +65.9% | 0.18% | -30.2% |
| Q1 2016 | $187,000 | -34.4% | 14,788 | -5.9% | 0.26% | -67.0% |
| Q4 2015 | $285,000 | – | 15,716 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |